Yetunde Balogun, MD
Surgery · Philadelphia, PANPI 1306129713
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (44.8%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $5,777 and has fallen 90.7% since, to $537 in 2025.
Across 112 payments — averaging $99.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- W. L. Gore & Associates, Inc.$1K
- Inari Medical, Inc.$899
- Stryker$308
- Endologix LLC$288
- Penumbra, Inc.$181
- plus $497 from 10 others
What the payments were for
- Grants$5,00045%
- Travel & lodging$1,26411%
- Food & beverage$3,30730%
- Education$1,58814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 45 | $7,749 |
| W. L. Gore & Associates, Inc. | 12 | $1,237 |
| Inari Medical, Inc. | 24 | $899 |
| Stryker | 12 | $308 |
| Endologix LLC | 4 | $288 |
| Penumbra, Inc. | 2 | $181 |
| Avinger Inc. | 2 | $104 |
| Shockwave Medical, Inc | 1 | $102 |
| Boston Scientific | 2 | $73 |
| Angiodynamics, Inc. | 2 | $58 |
| BD | 1 | $49 |
| Atricure, Inc. | 1 | $27 |
| Abbott | 1 | $25 |
| Teleflex LLC | 1 | $24 |
| Solventum Corporation | 1 | $22 |
| Terumo Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$5,000
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,156
- EXCLUDER AAA Endoprosthesis$315
- Vascular Graft$259
- FLOWTRIEVER CATHETER, S$206
- GORE TAG Thoracic Branch Endoprosthesis$158
- Indigo System$125
- GORE EXCLUDER AAA Endoprosthesis$119
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$102
- Alto Abdominal Stent Graft System$101
How this compares
$11,159 in reported general payments places this provider in the 85th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 37 | $32,609 |
| XareltoRivaroxaban | 13 | $16,932 |
| ClopidogrelClopidogrel Bisulfate | 75 | $1,370 |
| Atorvastatin Calcium | 29 | $478 |
| Cilostazol | 16 | $318 |
Paid to pharmacies, not to this prescriber.
Other surgery in Philadelphia
- Brett ChatmanPhiladelphia$178K
- David WernsingPhiladelphia$142K
- Said AzouryPhiladelphia$131K
- James MarkmannPhiladelphia$97K
- Daniel HewittPhiladelphia$89K
- Daniel HashimotoPhiladelphia$73K
- Scott KozinPhiladelphia$59K
- Prashanth PalvannanPhiladelphia$54K
- Henry HirschPhiladelphia$53K
- Erica PettkePhiladelphia$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.